About bit.bio

bit.bio uses synthetic biology to create human cells with unprecedented precision and consistency. The company's opti-ox technology reprograms induced pluripotent stem cells into any cell type at scale, providing researchers and drug developers with reliable, reproducible cell models that replace inconsistent methods and reduce animal testing. The technology serves research labs, pharmaceutical companies and therapeutic developers who need high quality human cells for drug screening, disease modelling and cell therapy. By making cell programming reliable and scalable, bit.bio accelerates biomedical innovation and helps bring new treatments to patients faster.